The Dry Powder Inhaler Devices market revenue was 680 Million USD in 2019, and will reach 886 Million USD in 2025, with a CAGR of 4.5% during 2020-2025. Dry powder inhaler is a medical device that is used for the effective delivery of medication to the lungs. The medication comes in the form of dry powder. The patients who suffer from various respiratory diseases make use of the dry powder inhalers as they are portable and are easy to carry.
This report elaborates the market size, market characteristics, and market growth of the Dry Powder Inhaler Devices industry, and breaks down according to the type, application, and consumption area of Dry Powder Inhaler Devices. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Dry Powder Inhaler Devices in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global Dry Powder Inhaler Devices market covered in Chapter 11:
Beximco Pharma Ltd.
Catalent, Inc.
Luckys Pharma
Teicos Pharma Ltd.
GlaxoSmithKline Plc.
Bespak Europe Ltd.
Hovione FarmaCiencia SA.
AstraZeneca Plc.
SRS Pharmaceuticals Pvt. Ltd
Cipla Inc.
Presspart Manufacturing Ltd.

In Chapter 3, on the basis of types, the Dry Powder Inhaler Devices market from 2015 to 2025 is primarily split into:
Single dose inhalers
Multi-dose inhalers

In Chapter 4, on the basis of applications, the Dry Powder Inhaler Devices market from 2015 to 2025 covers:
Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025